Home
About
Overview
Sharing Data
ORCID
Help
History (28)
Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors.
Apocynum
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.
Pharmacological blockade of TEAD-YAP reveals its therapeutic limitation in cancer cells.
Task Force 11: commotio cordis.
See All 28 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Task Force 11: commotio cordis.
Maron BJ, Estes NA, Link MS. Task Force 11: commotio cordis. J Am Coll Cardiol. 2005 Apr 19; 45(8):1371-3.
View in:
PubMed
subject areas
Athletic Injuries
Death, Sudden, Cardiac
Health Planning Guidelines
Humans
Thoracic Injuries
Ventricular Fibrillation
Wounds, Nonpenetrating
authors with profiles
Barry J Maron MD